Login / Signup

Opportunities and challenges following approval of resmetirom for MASH liver disease.

Jeffrey Victor LazarusDana Ivancovsky WajcmanHenry E MarkZobair M YounossiChristopher J KopkaNevin CohenMeena B BansalMichael BetelPaul Noel Brennan
Published in: Nature medicine (2024)
Keyphrases
  • drug administration